Molecular Marker Identification for Relapse Prediction in 5-FU-Based Adjuvant Chemotherapy in Gastric and Colorectal Cancers

• Kazushige Ishida,

  Current address: Chemical Immunology Section, Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  Affiliation Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Satoshi S. Nishizuka ,

  * E-mail: snishizu@iwate-med.ac.jp

  Affiliations Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan, MIAST (Medical Innovation by Advanced Science and Technology), Iwate Medical University, Morioka, Japan

  ⨯
• Takehiro Chiba,

  Current address: Department of Gastroenterological Surgery, Cancer Institute Hospital, Tokyo, Japan

  Affiliation Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Miyuki Ikeda,

  Affiliation Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Kohei Kume,

  Affiliations Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan, MIAST (Medical Innovation by Advanced Science and Technology), Iwate Medical University, Morioka, Japan, Department of Tumor Biology, Center for Advanced Medical Science, Iwate Medical University, Yahaba, Japan

  ⨯
• Fumitaka Endo,

  Affiliation Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Hirokatsu Katagiri,

  Affiliation Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Teppei Matsuo,

  Affiliation Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Hironobu Noda,

  Affiliation Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Takeshi Iwaya,

  Affiliations Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan, Department of Surgery, Medical Institute of Bioregulation, Kyushu University, Beppu, Japan

  ⨯
• Noriyuki Yamada,

  Affiliation Division of Diagnostic Molecular Pathology, Department of Pathology, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Hisataka Fujiwara,

  Affiliation Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Masanori Takahashi,

  Affiliation Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Tetsuya Itabashi,

  Affiliation Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Noriyuki Uesugi,

  Affiliations MIAST (Medical Innovation by Advanced Science and Technology), Iwate Medical University, Morioka, Japan, Division of Diagnostic Molecular Pathology, Department of Pathology, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Chihaya Maesawa,

  Affiliations MIAST (Medical Innovation by Advanced Science and Technology), Iwate Medical University, Morioka, Japan, Department of Tumor Biology, Center for Advanced Medical Science, Iwate Medical University, Yahaba, Japan

  ⨯
• Gen Tamura,

  Affiliation Department of Pathology and Laboratory Medicine, Yamagata Prefectural Central Hospital, Yamagata, Japan

  ⨯
• Tamotsu Sugai,

  Affiliation Division of Diagnostic Molecular Pathology, Department of Pathology, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Koki Otsuka,

  Affiliation Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
• Keisuke Koeda,

  Affiliation Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan

  ⨯
•  [ ... ],
• Go Wakabayashi

  Affiliations Department of Surgery, Iwate Medical University School of Medicine, Morioka, Japan, MIAST (Medical Innovation by Advanced Science and Technology), Iwate Medical University, Morioka, Japan

  ⨯
• [ view all ]
• [ view less ]